LAZTREVLA Trademark

Trademark Overview


On Wednesday, October 31, 2018, a trademark application was filed for LAZTREVLA with the United States Patent and Trademark Office. The USPTO has given the LAZTREVLA trademark a serial number of 88175882. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 6, 2020. This trademark is owned by Revance Therapeutics, Inc. The LAZTREVLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes
laztrevla

General Information


Serial Number88175882
Word MarkLAZTREVLA
Filing DateWednesday, October 31, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 6, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 15, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRevance Therapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Party NameRevance Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events


Event DateEvent Description
Monday, January 6, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 6, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 25, 2019ASSIGNED TO LIE
Thursday, February 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 7, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, February 7, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 5, 2019ASSIGNED TO EXAMINER
Thursday, November 15, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 3, 2018NEW APPLICATION ENTERED IN TRAM